Use of tumor markers in testicular, prostate, colorectal, breast and ovarian cancers

被引:0
|
作者
Duffy, Michael J.
Esteva, Francisco J.
Harbeck, Nadia
Hayes, Daniel F.
Molina, Rafael
机构
来源
关键词
PLASMINOGEN-ACTIVATOR UPA; MINIMUM CLINICAL RECOMMENDATIONS; INTERNATIONAL EXPERT CONSENSUS; LIGAND-BINDING ASSAY; ESTROGEN-RECEPTOR; GENE-EXPRESSION; PROGESTERONE-RECEPTOR; FOLLOW-UP; ADJUVANT CHEMOTHERAPY; PREDICTING RESPONSE;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:731 / 747
页数:17
相关论文
共 50 条
  • [1] Use of tumor markers in testicular, prostate, colorectal, breast and ovarian cancer
    Lilja, Hans
    Babaian, Richard
    Dowell, Barry
    Klee, George G.
    Rittenhouse, Harry
    Semjonow, Axel
    Sibley, Paul
    Sokoll, Lori
    Stephan, Carsten
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2013, 47 (02): : 435 - 452
  • [2] National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
    Sturgeon, Catharine M.
    Duffy, Michael J.
    Stenman, Ulf-Hakan
    Lilja, Hans
    Brunner, Nils
    Chan, Daniel W.
    Babaian, Richard
    Bast, Robert C., Jr.
    Dowell, Barry
    Esteva, Francisco J.
    Haglund, Caj
    Harbeck, Nadia
    Hayes, Daniel F.
    Holten-Andersen, Mads
    Klee, George G.
    Lamerz, Rolf
    Looijenga, Leendert H.
    Molina, Rafael
    Nielsen, Hans Jorgen
    Rittenhouse, Harry
    Semjonow, Axel
    Shih, Ie-Ming
    Sibley, Paul
    Soletormos, Gyorgy
    Stephan, Carsten
    Sokoll, Lori
    Hoffman, Barry R.
    Diamandis, Eleftherios P.
    CLINICAL CHEMISTRY, 2008, 54 (12) : E11 - E79
  • [3] Tumor antigens and markers for breast and ovarian cancers
    Ghadersohi, A
    Chitta, K
    Greco, WR
    Harvey, S
    Winston, J
    Slocum, H
    Odunsi, K
    Sood, AK
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2002, 7 : E48 - E57
  • [4] Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
    Larionova, Irina
    Tuguzbaeva, Gulnara
    Ponomaryova, Anastasia
    Stakheyeva, Marina
    Cherdyntseva, Nadezhda
    Pavlov, Valentin
    Choinzonov, Evgeniy
    Kzhyshkowska, Julia
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [5] Targeting breast, prostate, ovarian, and testicular cancers through their hormone receptors
    Hansel, W
    BIOLOGY OF REPRODUCTION, 2005, 73 (05) : 850 - 850
  • [6] Serum markers for breast and colorectal cancers
    Mlika-Cabanne, N
    Bellet, D
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1998, 22 (04): : 442 - 457
  • [7] 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer
    Bast, RC
    Desch, CE
    Hayes, DF
    Kemeny, NE
    Ravdin, P
    Somerfield, MR
    Smith, TJ
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) : 793 - 795
  • [8] Use of tumor markers in cancer of testicles, prostata, colorectal, breast and ovary
    Bruenner, Nils
    Duffy, Michael J.
    Haglund, Caj
    Holten-Andersen, Mads
    Nielsen, Hans Jorgen
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2013, 47 (03): : 595 - 607
  • [9] Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer
    Bast, RC
    Bates, S
    Bredt, AB
    Desch, CE
    Fritsche, H
    Fues, L
    Hayes, DF
    Kemeny, NE
    Kragen, M
    Jessup, J
    Locker, GY
    Macdonald, JS
    Mennel, RG
    Norton, L
    Ravdin, P
    Smith, TJ
    Taube, S
    Winn, RJ
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) : 2843 - 2877
  • [10] Comparing the Association Between Insurance and Mortality in Ovarian, Pancreatic, Lung, Colorectal, Prostate and Breast Cancers
    Cole, Alexander P.
    Lu, Chang
    Krimphove, Marieke J.
    Szymaniak, Julie
    Sun, Maxine
    Fletcher, Sean A.
    Lipsitz, Stuart R.
    Mahal, Brandon A.
    Nguyen, Paul L.
    Choueiri, Toni K.
    Kibel, Adam S.
    Haider, Adil H.
    Quoc-Dien Trinh
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (09): : 1049 - +